History of falls in Parkinson disease is associated with reduced cholinergic activity
about
Brainstem control of locomotion and muscle tone with special reference to the role of the mesopontine tegmentum and medullary reticulospinal systemsPedunculopontine Nucleus Stimulation: Where are We Now and What Needs to be Done to Move the Field Forward?Neuroimaging of mobility in aging: a targeted reviewGait and cognition: a complementary approach to understanding brain function and the risk of fallingFunctional neuroimaging in Parkinson's diseaseBalance dysfunction in Parkinson's diseaseNucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseNeuromechanical principles underlying movement modularity and their implications for rehabilitationPharmacotherapies for Parkinson's disease symptoms related to cholinergic degeneration.Linear and Curvilinear Trajectories of Cortical Loss with Advancing Age and Disease Duration in Parkinson's Disease.Effect of low versus high frequency stimulation on freezing of gait and other axial symptoms in Parkinson patients with bilateral STN DBS: a mini-review.StartReact effects support different pathophysiological mechanisms underlying freezing of gait and postural instability in Parkinson's disease.The contribution of proprioceptive information to postural control in elderly and patients with Parkinson's disease with a history of falls.Pharmacogenetic stimulation of cholinergic pedunculopontine neurons reverses motor deficits in a rat model of Parkinson's diseaseImaging: What can it tell us about parkinsonian gait?Neuroimaging as a window into gait disturbances and freezing of gait in patients with Parkinson's disease.Demographic study of parkinson's disease in Iran: Data on 1656 casesCholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways.Neuroimaging in Parkinson disease: from research setting to clinical practice.Neuroimaging of Freezing of Gait.The contribution of white matter lesions to Parkinson's disease motor and gait symptoms: a critical review of the literature.The ReSPonD trial--rivastigmine to stabilise gait in Parkinson's disease a phase II, randomised, double blind, placebo controlled trial to evaluate the effect of rivastigmine on gait in patients with Parkinson's disease who have fallen.Objective assessment of fall risk in Parkinson's disease using a body-fixed sensor worn for 3 days.White matter lesions in Parkinson disease.Deficits in cholinergic neurotransmission and their clinical correlates in Parkinson's disease.Cognitive contributions to gait and falls: evidence and implicationsEffects of a central cholinesterase inhibitor on reducing falls in Parkinson diseaseExtra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study.Defining optimal cutoff scores for cognitive impairment using Movement Disorder Society Task Force criteria for mild cognitive impairment in Parkinson's disease.An update on brain imaging in parkinsonian dementiaRhinorrhea: a common nondopaminergic feature of Parkinson's disease.Predictors of cognitive impairment in an early stage Parkinson's disease cohortAdvanced age, cardiovascular risk burden, and timed up and go test performance in Parkinson disease.Effects of levodopa on regional cerebral metabolism and blood flowClinical markers for identifying cholinergic deficits in Parkinson's diseaseModeling falls in Parkinson's disease: Slow gait, freezing episodes and falls in rats with extensive striatal dopamine lossLeucoaraiosis, nigrostriatal denervation and motor symptoms in Parkinson's disease.The interplay between gait, falls and cognition: can cognitive therapy reduce fall risk?Glial response in the rat models of functionally distinct cholinergic neuronal denervations.Modeling Parkinson's disease falls associated with brainstem cholinergic systems decline.
P2860
Q26779826-28CE4846-8D7C-4594-84C5-12D56DD75993Q26852043-01C8DE3A-FA73-4B8B-A2D8-BA98563E3C2FQ26853463-551DDD2B-D208-45AB-8002-7605D26875CCQ26992286-570FFC5A-DB5D-47FE-84CD-AFAF743BA8ACQ27013767-7B38182B-DEF7-43B0-8ADF-B7D80A0579D2Q28081188-2603ACE5-5334-4CB0-9764-95B38E326F3DQ28085513-25699E1F-0EB2-4F6E-AD3D-6A3F5C358B9DQ28088572-6E5ED293-DB9D-4B4D-811F-C528250E8AD4Q30244035-A179DA39-09E2-4D7E-B250-B5E161A20FB6Q30276531-0E278B6C-815C-4257-A14B-554DA4AF5F76Q30356041-CE874CDC-2130-44F4-B61F-07B845ED6BBEQ30414951-DD861013-92E0-4DE6-B996-05A4174C621AQ30601341-513353D3-2423-4474-9656-946B68CD7DBAQ30665304-022708DE-5A97-43B6-94D7-E84A595EF1E2Q30678856-A9288826-7CA2-4DB5-BE4A-C2B59CBA0CBEQ30679603-DC127B85-09E3-4B66-BBD6-EAA8D426F58EQ30697523-F9BD2446-A125-4C56-BC56-C8786BD8271DQ30746347-716F1E21-C29E-4B7E-84D0-9C3AB650EB6FQ30868628-6FD4324F-D78E-4E5C-BCCE-03B072CA2E1EQ30908233-73B361B9-8253-4150-8CC9-DBF19F8B608EQ31008210-CC360F5A-5357-4C52-9F7B-41173D1C61BEQ31145409-5523137A-E741-4113-ACBF-6F98AE6F66E8Q33573126-F445FC47-057B-4836-8802-8FBA4713646CQ33827305-DB1A8A4D-F713-4724-A915-147136DA1E67Q33917311-C70EA953-9C07-45EA-8C93-955A129E6CC9Q33993839-03D564D1-35B1-48BC-924B-C3CC01D6B2E5Q34135495-9EF6590F-898C-44DC-9469-9F867F5AE487Q34170501-E28DA8E7-6DFD-49F9-962A-E4D88B859B17Q34183061-70B092C9-7DE8-41EF-85B1-7E93E1B8DD4BQ34327937-656475B5-2F47-497D-B5BA-0981C3FFFF58Q34440927-2D0A24C2-8F0C-41F4-8F97-0D392E9B9185Q34531319-1BBF1A16-00C5-4B44-8815-66D67F01D70DQ34974523-20D0EAD2-28E0-42DB-8897-7E237C3D7820Q35040119-91E40547-EBBC-435E-9681-7D576D543495Q35054623-F3A31CBB-99DE-4D21-B5BE-A55B7641CE64Q35070996-11B24C72-D9BF-471B-9C14-941E0D11A532Q35163173-D28C463B-9FD3-49EF-84BB-A636757E25D9Q35186701-4929B761-4846-4350-8F3A-C35842BFCAE9Q35273342-0E2DCA42-A8DB-46A4-8817-B664268F8F95Q35360176-D864EA56-7C7B-44E8-83EC-A383B67B57B1
P2860
History of falls in Parkinson disease is associated with reduced cholinergic activity
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
History of falls in Parkinson disease is associated with reduced cholinergic activity
@en
History of falls in Parkinson disease is associated with reduced cholinergic activity.
@nl
type
label
History of falls in Parkinson disease is associated with reduced cholinergic activity
@en
History of falls in Parkinson disease is associated with reduced cholinergic activity.
@nl
prefLabel
History of falls in Parkinson disease is associated with reduced cholinergic activity
@en
History of falls in Parkinson disease is associated with reduced cholinergic activity.
@nl
P2093
P2860
P1433
P1476
History of falls in Parkinson disease is associated with reduced cholinergic activity
@en
P2093
M A Kilbourn
M L T M Müller
N I Bohnen
R A Koeppe
S A Studenski
P2860
P304
P356
10.1212/WNL.0B013E3181C1DED6
P407
P577
2009-11-01T00:00:00Z